<DOC>
	<DOCNO>NCT02595359</DOCNO>
	<brief_summary>The aim study evaluate efficacy safety prophylactic effect intracameral moxifloxacin prevention postcataract endophthalmitis .</brief_summary>
	<brief_title>Intracameral Moxifloxacin Prevention Postcataract Endophthalmitis</brief_title>
	<detailed_description>Although cataract surgery generally consider safe procedure result favourable visual outcome , surgical complication occur . The feared complication postoperative endophthalmitis infectious condition cause micro-organism introduce interior eye surgical procedure . As endophthalmitis infection , preventable antibiotic treatment . Prophylactic antibiotic treatment give topical treatment preoperatively , surgery directly anterior chamber , subconjunctival , give topical treatment postoperatively . The aim study evaluate efficacy safety prophylactic effect intracameral moxifloxacin prevention postcataract endophthalmitis .</detailed_description>
	<mesh_term>Endophthalmitis</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Diagnosis visually significant cataract Has know allergy moxifloxacin Has significant ocular comorbidities one eye may include ( limited ) : advanced glaucoma , advance active macular degeneration , Fuchs corneal dystrophy , prior corneal transplantation , advance diabetic eye disease , history retinal detachment patient would require billing complex cataract procedure reason Has know history condition cause immunocompromised host state</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>endophthalmitis</keyword>
	<keyword>antibiotic therapy</keyword>
	<keyword>cataract surgery</keyword>
	<keyword>prevention</keyword>
</DOC>